F45 Training Holdings Inc., a leading global fitness community known for innovative, high-energy group workouts, announced ...

The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for the next 12 months.Many resolutions ...

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

Highmark Health President and CEO David Holmberg discussed the uncertainties facing the insurance industry, including the ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence ...

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...

Their top 10 list includes GLP-1 drugs, salt and sugar reduction and growing use of AI, in the lab and at home.

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.